Schedule 13D Page 1 of 6
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)
THE MEDICINES COMPANY, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.001 Par Value
--------------------------------------------------------------------------------
(Title of Class of Securities)
584688 10 5
--------------------------------------------------------------------------------
(CUSIP Number)
Scott A. Arenare, Esq.
Managing Director and General Counsel
Warburg Pincus LLC
466 Lexington Avenue
New York, New York 10017
(212) 878-0600
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
Copies to:
Peter H. Jakes, Esq.
Willkie Farr & Gallagher
787 Seventh Avenue
New York, New York 10019-6099
(212) 728-8000
July 25, 2002
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-l(e), 240.13d-l(f) or 240.13d-1(g), check the
following box. [ ]
Schedule 13D Page 2 of 6
CUSIP No.584688 10 5
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R. S. Nos. of above persons (entities
only).
Warburg, Pincus Ventures, L.P. I.R.S. #13-3784037
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [x]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions)
WC
--------------------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization
Delaware
------- ------------------------------------------------------------------------
Number of
Shares 7. Sole Voting Power
Beneficially Owned
by
Each 0
Reporting Person
With
-----------------------------------------------------------
8. Shared Voting Power
9,138,757
-----------------------------------------------------------
9. Sole Dispositive Power
0
-----------------------------------------------------------
10. Shared Dispositive Power
9,138,757
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
9,138,757
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) [ ]
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11) 22.7%
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
PN
--------------------------------------------------------------------------------
Schedule 13D Page 3 of 6
CUSIP No.584688 10 5
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R. S. Nos. of above persons (entities
only).
Warburg, Pincus & Co. I.R.S. #13-6358475
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [x]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions)
WC
--------------------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization
New York
--------------------------------------------------------------------------------
Number of
Shares 7. Sole Voting Power
Beneficially Owned
by
Each 0
Reporting Person
With
-----------------------------------------------------------
8. Shared Voting Power
9,138,757
-----------------------------------------------------------
9. Sole Dispositive Power
0
-----------------------------------------------------------
10. Shared Dispositive Power
9,138,757
------------ -------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
9,138,757
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) [ ]
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11) 22.7%
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
PN
--------------------------------------------------------------------------------
Schedule 13D Page 4 of 6
CUSIP No.584688 10 5
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R. S. Nos. of above persons (entities
only).
Warburg Pincus LLC
(formerly E.M. Warburg, Pincus & Co., LLC) I.R.S. #13-3536050
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [x]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions)
WC
--------------------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization
New York
--------------------------------------------------------------------------------
Number of
Shares 7. Sole Voting Power
Beneficially Owned
by
Each 0
Reporting Person
With
-----------------------------------------------------------
8. Shared Voting Power
9,138,757
-----------------------------------------------------------
9. Sole Dispositive Power
0
-----------------------------------------------------------
10. Shared Dispositive Power
9,138,757
-------------------- -----------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
9,138,757
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) [ ]
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11) 22.7%
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
OO
--------------------------------------------------------------------------------
Schedule 13D Page 5 of 6
This Amendment No. 1 amends the Schedule 13D filed on May 23, 2001 (as
amended the "Schedule 13D") on behalf of Warburg, Pincus Ventures, L.P., a
Delaware limited partnership ("Ventures"), Warburg, Pincus & Co., a New York
general partnership ("WP") and Warburg Pincus LLC (formerly E.M. Warburg, Pincus
& Co., LLC), a New York limited liability company ("WP LLC" and, together with
Ventures and WP, the "Reporting Entities"). This Schedule 13D relates to the
Common Stock, par value $0.001, of The Medicines Company, Inc., a corporation
organized under Delaware law (the "Company"). Unless the context otherwise
requires, references herein to the "Common Stock" are to the Common Stock of the
Company, par value $0.001 per share.
Unless otherwise indicated herein, each capitalized term used but not
defined herein shall have the meaning assigned to such term in the Schedule 13D.
Item 5. Interest in Securities of the Issuer
Item 5 of the Schedule 13D is hereby amended by adding the following:
On July 25, 2002, Ventures distributed an aggregate of 1,516,499 shares of
Common Stock to its partners. As of such date and after giving effect to the
distribution, the Reporting Persons beneficially owned 9,138,757 shares of
Common Stock, or approximately 22.7% of the shares of Common Stock outstanding
(comprised of (i) 39,025,958 shares of Common Stock outstanding as of June 21,
2002; and (ii) 1,275,810 additional shares of Common Stock issuable on the
exercise of the immediately exercisable warrants held by Ventures).
Schedule 13D Page 6 of 6
Signatures
After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
Dated: July 29, 2002 WARBURG, PINCUS VENTURES, L.P.
By: Warburg, Pincus & Co.,
General Partner
By: /s/ Scott A. Arenare
------------------------------
Name: Scott A. Arenare
Title: General Partner
Dated: July 29, 2002 WARBURG, PINCUS & CO.
By: /s/ Scott A. Arenare
------------------------------
Name: Scott A. Arenare
Title: General Partner
Dated: July 29, 2002 WARBURG PINCUS LLC
By: /s/ Scott A. Arenare
------------------------------
Name: Scott A. Arenare
Title: Managing Director